SCHEMBL8140692

SCHEMBL8140692

NS(=O)(=O)c1ccc(-c2ocnc2-c2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 12/20 0.60
▸ CA1 P00915 11/20 0.60
▸ CA9 Q16790 10/20 0.60
▸ CA12 O43570 9/20 0.60
▸ PTGS2 P35354 8/20 0.57
▸ MAOA P21397 1/20 0.53
▸ MAOB P27338 1/20 0.53
▸ PTGS1 P23219 3/20 0.51
▸ CA14 Q9ULX7 2/20 0.51
▸ MT-CO2 P00403 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ CA3 P07451 1/20 0.51
▸ ADRB2 P07550 1/20 0.51
▸ ADRB1 P08588 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ ADORA3 P0DMS8 1/20 0.51
▸ CHRM1 P11229 1/20 0.51
▸ ADRA2B P18089 1/20 0.51
▸ CA4 P22748 1/20 0.51
▸ CA6 P23280 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6481054 0.83 MAPK14 (0.58) CYP3A4
SCHEMBL6454036 0.82 CA1 (0.60) CA2CA1CA9CA12PTGS2
SCHEMBL926216 0.82 MAPK14 (0.55) CYP3A4
SCHEMBL24212672 0.76 MAPK14 (0.49) LMNATDP1
SCHEMBL2778903 0.76 MAPK14 (0.73) —
SCHEMBL8550933 0.75 CA2 (0.59) CA2CA1CA9CA12PTGS2
SCHEMBL308881 0.74 CA2 (1.00) CA2CA1CA9CA12PTGS2
SCHEMBL6482321 0.74 CA2 (1.00) CA2CA1CA9CA12PTGS2
SCHEMBL8149351 0.74 CA2 (0.57) CA2CA1CA9CA12PTGS2
SCHEMBL6024882 0.74 CA2 (0.57) CA2CA1CA9CA12PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP claimed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO claimed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
Send feedback